LakeShore Biopharma Co Total Current Liabilities

LakeShore Biopharma Co (LSB) currently reports a total current liabilities of $820M as of March 2025. That compares with $800M in the prior-year period — up 2.8% year over year. Use the charts on this page to explore LakeShore Biopharma Co's total current liabilities history and peer comparisons.

LakeShore Biopharma Co's total current liabilities increased from $800M to $820M — a 2.8% year-over-year increase (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

LakeShore Biopharma Co reported $820M in total current liabilities as of March 2025. That compares with $800M in the prior-year period — up 2.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $820M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for LakeShore Biopharma Co, and consider following LSB for alerts when major investors trade the stock.